Survival from Multiple Myeloma in England and Wales
Author Information
Author(s): Schey S
Primary Institution: King's College Hospital
Conclusion
Survival rates for multiple myeloma have improved over the years, particularly for younger patients.
Supporting Evidence
- Survival rates have improved for patients under 60 years of age due to advancements in treatment.
- Autologous stem cell transplantation has significantly impacted survival rates.
- Socioeconomic factors play a crucial role in access to treatment for multiple myeloma.
Takeaway
Doctors are finding better ways to help people with multiple myeloma live longer, especially younger patients.
Methodology
The study analyzed survival data from multiple myeloma patients diagnosed between 1990 and 1999 across 580 centers in Europe.
Potential Biases
There may be biases related to socioeconomic status affecting patient access to effective therapies.
Limitations
The study may not fully represent all demographic groups due to socioeconomic factors affecting access to treatment.
Participant Demographics
The study included a diverse population of patients, with a noted higher incidence in the African-Caribbean population.
Statistical Information
P-Value
0.02
Statistical Significance
p=0.02
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website